Showing 1 - 10 of 14,032
patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the … biotherapeutics tocilizumab, siltuximab and sarilumab. … support national patent offices and interested parties in developing countries with information that can serve as guidance for …
Persistent link: https://www.econbiz.de/10013194325
Persistent link: https://www.econbiz.de/10012433647
Persistent link: https://www.econbiz.de/10012433890
Despite multilateral commitments and political statements of solidarity and cooperation to guarantee the availability and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the beginning of vaccination is marked by the deepening of vaccine...
Persistent link: https://www.econbiz.de/10012496070
Persistent link: https://www.econbiz.de/10012433673
nations and the health of their people. Various initiatives have been launched to overcome the dependence of African nations … diversification of African economies and strengthen the capacity of nations on the continent to address their public health needs …
Persistent link: https://www.econbiz.de/10014284597
The purpose of this report is to analyze the impact that the COVID-19 pandemic has had on the vaccine industry from an … paradigm of competitive market efficiency with notorious market failures. We examine the impact of the pandemic on innovation …
Persistent link: https://www.econbiz.de/10014637110
Persistent link: https://www.econbiz.de/10014364285
Persistent link: https://www.econbiz.de/10012433565
This paper aims to analyze the interfaces between Brazilian Competition Law and the issue of access to medicines, with a special focus on abuse of industrial property rights and related exclusionary and exploitative effects. The paper analyzes the case law of Brazilian Administrative Council for...
Persistent link: https://www.econbiz.de/10013365665